CI Investments Inc
ALLO icon

CI Investments Inc’s Allogene Therapeutics ALLO Stock Holding History

CI Investments Inc’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,936
Closed -$47K – 1268
2023
Q3 		$47K Sell
14,936
-445
-3% -$1.95K ﹤0.01% 979
2023
Q2 		$76K Buy
15,381
+6,494
+73% +$35.1K ﹤0.01% 850
2023
Q1 		$44K Sell
8,887
-115
-1% -$738 ﹤0.01% 928
2022
Q4 		$57K Buy
9,002
+6,961
+341% +$64.4K ﹤0.01% 892
2022
Q3 		$22K Sell
2,041
-152
-7% -$2.07K ﹤0.01% 1013
2022
Q2 		$25K Buy
2,193
+978
+80% +$8.68K ﹤0.01% 938
2022
Q1 		$11K Buy
+1,215
New +$12.7K ﹤0.01% 1081

Other funds holding ALLO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

CI Investments Inc's ALLO Position: Q4 2023 in Review

CI Investments Inc sold out of Allogene Therapeutics (ALLO) in Q4 2023, closing a stake of 14,936 shares — an estimated $47K sold.

CI Investments Inc first reported a position in ALLO in Q1 2022 and held it in 7 quarters. The position peaked at $76K in Q2 2023. 170 funds tracked by Wall St. Rank hold ALLO as of Q4 2023.

  • CI Investments Inc reported no remaining Allogene Therapeutics position as of Q4 2023 after selling out during the quarter.
  • CI Investments Inc sold 14,936 Allogene Therapeutics shares in Q4 2023, an estimated $47K.
  • CI Investments Inc first reported a position in Allogene Therapeutics in Q1 2022 and held it in 7 quarters.
  • CI Investments Inc's Allogene Therapeutics position peaked at $76K in Q2 2023.
  • 170 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q4 2023.

Based on CI Investments Inc's 13F filing for Q4 2023, filed 12 Feb 2024.